Literature DB >> 30968778

P Wave Dispersion and Silent Atrial Fibrillation in Cryptogenic Stroke: The Pathogenic Role of Inflammation.

Maurizio Acampa1, Pietro E Lazzerini2, Francesca Guideri1, Rossana Tassi1, Alessandra Cartocci3, Giuseppe Martini1.   

Abstract

BACKGROUND: Cryptogenic stroke (CS) represents 25% of ischemic strokes. Especially after CS, the detection of atrial fibrillation (AF) is important because it provides clues to the mechanism of stroke. However, the relationship between AF and stroke appears more complex than a simple cause-effect mechanism, suggesting that the association between AF and stroke may be due to other systemic and atrial factors including systemic inflammation that may lead to atrial remodeling and subsequent atrial cardiopathy.
OBJECTIVE: The aim of this study was to evaluate the relationship among different electrocardiographic parameters, inflammatory markers and in-hospital AF occurrence after acute CS.
METHODS: 222 patients with CS underwent 12-lead resting ECG at admission and 7-day in-hospital ECG monitoring. The following indices were evaluated: P-wave dispersion (PWD), P-wave index, P-wave axis, atrial size and high-sensitivity-C reactive protein (CRP).
RESULTS: AF was detected in 44 patients. AF-group had significantly higher PWD, P-wave index, PR interval, CRP and greater frequency of abnormal P-wave axis in comparison with no-AF group. There was a significant correlation between CRP and PWD (r=0.28). By using the mediation analysis, performed according to the "bootstrapping" method, we found that PWD is a significant mediator variable of the relationship between CRP and AF occurrence, accounting for 40% of the association.
CONCLUSIONS: In cryptogenic stroke, high PWD is partly due to systemic inflammation that increases AF risk possibly via atrial electric remodeling. These findings could also suggest inflammation as a possible therapeutic target in order to prevent atrial electrical alterations and finally AF occurrence in CS. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  C reactive protein; Ischemic stroke; P wave dispersion; atrial cardiopathy; atrial fibrillation; cryptogenic stroke; electrocardiogram; inflammation.

Year:  2019        PMID: 30968778     DOI: 10.2174/1871529X19666190410145501

Source DB:  PubMed          Journal:  Cardiovasc Hematol Disord Drug Targets        ISSN: 1871-529X


  6 in total

1.  Comparison of serum Lp-PLA2 levels in ischemic stroke patients with H-type hypertension or non-H-type hypertension.

Authors:  Jie Qiao; KuiChen Zhou; Chao Huang; Siwen Fu; Yonghong Xing; Biao Zhang
Journal:  J Clin Lab Anal       Date:  2019-10-19       Impact factor: 2.352

2.  The relationship of benign prostatic hyperplasia's symptoms severity with the risk of developing atrial fibrillation.

Authors:  Ajar Koçak; Cem Şenol; Ayhan Coşgun; Ferhat Eyyupkoca; Onur Yıldırım
Journal:  J Arrhythm       Date:  2022-02-09

3.  Anterior Circulation Acute Ischemic Stroke in the Plateau of China: Risk Factors and Clinical Characteristics.

Authors:  Yujia Yan; Xiqiang Zhang; Hecheng Ren; Xingwei An; Wanpeng Fan; Jingbo Liang; Ying Huang
Journal:  Front Neurol       Date:  2022-04-13       Impact factor: 4.003

4.  Markers of Atrial Cardiopathy in Severe Embolic Strokes of Undetermined Source.

Authors:  Maurizio Acampa; Alessandra Cartocci; Carlo Domenichelli; Rossana Tassi; Francesca Guideri; Pietro Enea Lazzerini; Giuseppe Martini
Journal:  Front Cardiovasc Med       Date:  2022-06-20

5.  The immediate trends in atrial electrical remodeling for paroxysmal atrial fibrillation across different modes of catheter ablation.

Authors:  Qian Hou; Liang Feng; Jing Yang; Yue Liu; Ling You; Lianxia Wang; Yan Zhang; Qian Liu; Yuliang Zhao; Ruiqin Xie
Journal:  Clin Cardiol       Date:  2021-06-01       Impact factor: 2.882

6.  Association of Interleukin-6-174G/C Polymorphism With Ischemic Stroke: An Updated Meta-Analysis.

Authors:  Jie Chai; Xian-Ling Cao; Feng Lu
Journal:  Front Neurol       Date:  2022-01-06       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.